Ozop Energy Solutions, Inc. Executes Marketing Agreement
Ozop to market GSFSGroup’s Vehicle Service Contracts for Electric Vehicles Warwick, NY, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Ozop Energy...
Month: August 2022
CURE Pharmaceutical Announces the Appointment of New Board Member
Gerald Bagg brings deep understanding of CPG to CUREOXNARD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp....
Y-mAbs to Announce Second Quarter 2022 Financial and Operating Results on August 8, 2022
NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that...
Simply Better Brands Corp. Announces 2022 Shareholder Meeting Results
VANCOUVER, British Columbia, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. (“SBBC” or the “Company”) (TSX Venture: SBBC)...
Yield10 Bioscience to Announce Second Quarter 2022 Financial Results and Host a Conference Call on Wednesday, August 10, 2022
WOBURN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,...
Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum
ROSELAND, N.J., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
WIMI Hologram Academy: Deep learning hardware technology based on in-memory computing structure
HONG KONG, Aug. 02, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022
Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CohBar,...
G1 Therapeutics to Participate Virtually in the 2022 BTIG Biotechnology Conference and the 2022 Wedbush Pacgrow Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...
Viemed Announces Executive Additions to Lead Acquisition Growth
LAFAYETTE, La., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national...
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
GreenLight Woburn lab 2 GreenLight’s messenger RNA production process is transferable to large-scale equipment and CMO facilitiesGreenLight’s messenger RNA production...
CURE Pharmaceutical Announces Teleconference With Investors
Updates on Recent Transaction and Business will be ProvidedOXNARD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp....
Novel Carbohydrate Antiviral Drug Candidate Acts Through Galectin Inhibition to Block SARS-CoV-2 Coronavirus
ProLectin-M, a new class of oral antiviral drug BOSTON, MASSACHUSETTS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (Symbol: BIXT)...
Altamira Therapeutics Completes Interim Sample Size Analysis of COVAMID Trial with Bentrio in Acute COVID-19
HAMILTON, BERMUDA , Aug. 01, 2022 (GLOBE NEWSWIRE) -- Enrollment to be continued to 160 subjects, adding 24 to ensure...
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME® (ibrexafungerp tablets) for Prevention of Recurrent Vaginal Yeast Infections
Submission has been granted priority review and given a target regulatory decision date of November 30, 2022.If approved for this...
Qualigen Therapeutics Reports Positive QN-247 Readout in Triple Negative Breast Cancer in Vivo Model
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on...
Nuvectis Pharma Announces Closing of Approximately $15.9 Million Private Placement
Fort Lee, NJ, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT) (“Nuvectis” or the “Company”), a biopharmaceutical...
Catalyst Biosciences Publishes New Investor Presentation
Provides Details on Current Board’s Cash Distribution Plan and Efforts to Maximize the Amount of Cash Available for Distribution Company...
Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD)
Ranked #1 in IFFGD Virtual Walk to spread awareness and support research for gastrointestinal disorders Evoke attending ANMS 2022 meeting...
LifeSci Partners Launches LifeSci Events, Life Sciences-focused Corporate Event Planning Agency
NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- LifeSci Partners, a life science focused consultancy, announced today the launch of...